EarningsQ4 2023 Earnings Report

Nektar Therapeutics (ITH0) Q4 2023 Earnings Report

1 Followers

DE:ITH0 Q4 2023 EPS Results

Actual EPS-€2.94

Consensus EPS-€2.81

Beat/MissMissed by -€0.13

One Year Ago EPS-€4.28

Actual Revenue€21.27M

Expected Revenue€19.09M

Beat/MissBeat by +€2.19M

YoY Revenue Growth+8.45%

QuarterQ4 2023

Date03/04/2024

TimeAfter Close

Conference CallMonday, March 4, 2024

DE:ITH0 Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

DE:ITH0 Q4 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-1.85 / -	-1.666	―
Aug 13, 2026	2026 (Q2)	-1.76 / -1.10	-2.628	58.31% (+1.53)
May 07, 2026	2026 (Q1)	-1.41 / -1.62	-3.207	49.44% (+1.59)
Mar 12, 2026	2025 (Q4)	-2.20 / -1.59	0.401	-495.56% (-1.99)
Nov 06, 2025	2025 (Q3)	-2.39 / -1.67	-2.405	30.74% (+0.74)
Aug 07, 2025	2025 (Q2)	-2.70 / -2.63	-3.34	21.33% (+0.71)
May 08, 2025	2025 (Q1)	-2.28 / -3.21	-2.538	-26.32% (-0.67)
Mar 12, 2025	2024 (Q4)	-1.81 / 0.40	-2.939	113.64% (+3.34)
Nov 07, 2024	2024 (Q3)	-2.66 / -2.40	-3.207	25.00% (+0.80)
Aug 08, 2024	2024 (Q2)	-2.47 / -3.34	-3.607	7.41% (+0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed